Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor
J. V.N. Vara Prasad, Frederick E. Boyer, John M. Domagala, Edmund L. Ellsworth, Christopher Gajda, Harriet W. Hamilton, Susan E. Hagen, Larry J. Markoski, Bruce A. Steinbaugh, Bradley D. Tait, Christine Humblet, Elizabeth A. Lunney, Alexander Pavlovsky, John R. Rubin, Donna Ferguson, Neil Graham, Tod Holler, Donald Hupe, Carolyn Nouhan, Peter J. TumminoA. Urumov, Eric Zeikus, Greg Zeikus, Stephen J. Gracheck, James M. Saunders, Steven Vanderroest, Joanne Brodfuehrer, K. Iyer, M. Sinz, Sergei V. Gulnik, John W. Erickson
Dive into the research topics of 'Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor'. Together they form a unique fingerprint.